Ovid Therapeutics Inc. Increase (Decrease) in Accrued Liabilities
Ovid Therapeutics Inc. (OVID) reported Increase (Decrease) in Accrued Liabilities of -$1.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$352.00K.
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$1.40M.
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $2.05M.
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $27.00K.
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$1.07M.
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$537.00K, a 126.57% decline from fiscal 2023.
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $2.02M.
- Ovid Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$3.17M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.75M 10-Q · filed 2026-08-13 | $298.00K derived: sum of 3 quarters · filed 2026-08-13 | $325.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$1.40M 10-Q · filed 2026-05-12 | $650.00K derived: sum of 2 quarters · filed 2026-05-12 | $677.00K derived: sum of 3 quarters · filed 2026-05-12 | -$2.47M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $2.08M derived: sum of 2 quarters · filed 2026-03-18 | -$1.07M derived: sum of 3 quarters · filed 2026-08-13 | -$1.07M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.12M derived: sum of 2 quarters · filed 2026-08-13 | -$3.12M 10-Q · filed 2025-11-12 | -$4.70M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$3.15M 10-Q · filed 2026-08-13 | -$4.73M derived: sum of 3 quarters · filed 2026-08-13 | -$5.27M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$1.00K 10-Q · filed 2026-05-12 | -$1.58M derived: sum of 2 quarters · filed 2026-05-12 | -$2.12M derived: sum of 3 quarters · filed 2026-05-12 | $1.95M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$2.12M derived: sum of 2 quarters · filed 2026-03-18 | $1.95M derived: sum of 3 quarters · filed 2026-03-18 | -$537.00K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | -$535.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.53M derived: sum of 2 quarters · filed 2025-11-12 | $1.05M 10-Q · filed 2025-11-12 | $1.35M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $4.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.58M 10-Q · filed 2025-08-13 | $1.89M derived: sum of 3 quarters · filed 2025-08-13 | $2.67M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$2.49M 10-Q · filed 2025-05-13 | -$2.18M derived: sum of 2 quarters · filed 2025-05-13 | -$1.39M derived: sum of 3 quarters · filed 2025-05-13 | -$46.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.09M derived: sum of 2 quarters · filed 2025-03-11 | $2.44M derived: sum of 3 quarters · filed 2025-03-11 | $2.02M 10-K · filed 2025-03-11 | $2.02M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | $789.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.14M derived: sum of 2 quarters · filed 2024-11-12 | $1.72M 10-Q · filed 2024-11-12 | $1.72M 10-Q · filed 2023-11-03 | $523.44K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $929.00K 10-Q · filed 2024-08-13 | $928.62K 10-Q · filed 2023-08-04 | -$265.56K derived: sum of 3 quarters · filed 2024-08-13 | $834.83K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$419.00K 10-Q · filed 2024-05-14 | -$419.30K 10-Q · filed 2023-05-05 | -$1.61M derived: sum of 2 quarters · filed 2024-05-14 | -$513.17K derived: sum of 3 quarters · filed 2024-05-14 | -$3.88M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$94.17K derived: sum of 2 quarters · filed 2024-03-08 | -$3.47M derived: sum of 3 quarters · filed 2024-03-08 | -$3.17M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$2.27M derived: sum of 2 quarters · filed 2023-11-03 | -$1.97M 10-Q · filed 2023-11-03 | -$1.22M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | -$3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$3.07M 10-Q · filed 2023-08-04 | -$2.32M derived: sum of 3 quarters · filed 2023-08-04 | -$5.76M derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2022-03-31 | $299.30K 10-Q · filed 2023-05-05 | $1.05M derived: sum of 2 quarters · filed 2023-05-05 | -$2.39M derived: sum of 3 quarters · filed 2023-05-05 | -$5.23M derived: sum of 4 quarters · filed 2023-05-05 | ||||
| 2021-12-31 | $748.26K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$2.68M derived: sum of 2 quarters · filed 2023-03-13 | -$5.53M derived: sum of 3 quarters · filed 2023-03-13 | -$4.36M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | -$3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$6.28M derived: sum of 2 quarters · filed 2022-11-08 | -$5.11M 10-Q · filed 2022-11-08 | -$4.50M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.68M 10-Q · filed 2022-08-09 | -$1.06M derived: sum of 3 quarters · filed 2022-08-09 | $484.63K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $1.17M 10-Q · filed 2022-05-10 | $1.78M derived: sum of 2 quarters · filed 2022-05-10 | $3.33M derived: sum of 3 quarters · filed 2022-05-10 | $7.28M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $612.21K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.16M derived: sum of 2 quarters · filed 2022-03-15 | $6.11M derived: sum of 3 quarters · filed 2022-03-15 | $4.84M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $5.50M derived: sum of 2 quarters · filed 2021-11-10 | $4.22M 10-Q · filed 2021-11-10 | $6.81M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $2.67M 10-Q · filed 2021-08-16 | $5.26M derived: sum of 3 quarters · filed 2021-08-16 | $2.81M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$1.28M 10-Q · filed 2021-05-13 | $1.31M derived: sum of 2 quarters · filed 2021-05-13 | -$1.15M derived: sum of 3 quarters · filed 2021-05-13 | $2.33M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $131.02K derived: sum of 2 quarters · filed 2021-03-15 | $3.61M derived: sum of 3 quarters · filed 2021-03-15 | $2.18M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | -$2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.02M derived: sum of 2 quarters · filed 2020-11-13 | -$407.17K 10-Q · filed 2020-11-13 | -$1.15M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.05M 10-Q · filed 2020-08-10 | $1.31M derived: sum of 3 quarters · filed 2020-08-10 | $3.07M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$1.43M 10-Q · filed 2020-05-07 | -$2.17M derived: sum of 2 quarters · filed 2020-05-07 | -$408.72K derived: sum of 3 quarters · filed 2020-05-07 | -$524.17K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$740.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.02M derived: sum of 2 quarters · filed 2020-03-11 | $906.56K derived: sum of 3 quarters · filed 2020-03-11 | $1.09M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.65M derived: sum of 2 quarters · filed 2019-11-08 | $1.83M 10-Q · filed 2019-11-08 | $2.68M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | -$115.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $71.51K 10-Q · filed 2019-08-07 | $914.88K derived: sum of 3 quarters · filed 2019-08-07 | $573.35K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $186.97K 10-Q · filed 2019-05-07 | $1.03M derived: sum of 2 quarters · filed 2019-05-07 | $688.81K derived: sum of 3 quarters · filed 2019-05-07 | $893.86K derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | $843.37K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $501.84K derived: sum of 2 quarters · filed 2019-03-07 | $706.90K derived: sum of 3 quarters · filed 2019-03-07 | $1.12M 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | -$341.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$136.47K derived: sum of 2 quarters · filed 2018-11-08 | $275.26K 10-Q · filed 2018-11-08 | $1.02M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $205.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $616.78K 10-Q · filed 2018-08-09 | $1.36M derived: sum of 3 quarters · filed 2018-08-09 | $1.43M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $411.73K 10-Q · filed 2018-05-08 | $1.16M derived: sum of 2 quarters · filed 2018-05-08 | $1.23M derived: sum of 3 quarters · filed 2018-05-08 | $2.35M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $744.73K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $815.67K derived: sum of 2 quarters · filed 2018-03-29 | $1.93M derived: sum of 3 quarters · filed 2018-03-29 | $1.24M 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | $70.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.19M derived: sum of 2 quarters · filed 2017-11-09 | $493.91K 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $422.97K 10-Q · filed 2017-08-10 | ||||||
| 2016-03-31 | -$695.89K 10-Q · filed 2017-06-13 | |||||||
| 2015-12-31 | $1.61M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |